However, additional human antibody sites within the core/stalk, GP1, and GP2 as well as the glycan cap have also been described following infection [53, 54], suggesting a more complex picture of immunoreactivity against EBOV GP and underscoring exactly which regions on GP are truly immunodominant in humans that are yet to be fully characterized. This evidence concerns the gene GTPBP1 and infection.